Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.

@article{Raymond2018LowsensitivityUP,
  title={Low-sensitivity urine pregnancy testing to assess medical abortion outcome: A systematic review.},
  author={Elizabeth G. Raymond and Tara Shochet and Hillary Bracken},
  journal={Contraception},
  year={2018},
  volume={98 1},
  pages={
          30-35
        }
}
View on PubMed
doi.org
15 Citations
Highly Influential Citations
1
Background Citations
2
Methods Citations
1

Tables from this paper

15 Citations

Efficacy of a low-sensitivity urine pregnancy test for identifying ongoing pregnancy after medication abortion at 64 to 70 days of gestation.

"False Positive" Urine Pregnancy Test Results after Successful Medication Abortion.

Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: A systematic review with meta-analyses.

Update on medication abortion follow-up options: many sizes to fit all

Remote, client-led follow-up options, such as urine pregnancy testing and symptoms evaluation, are well tolerated and effective for ruling out the rare outcome of ongoing pregnancy after medication abortion and have several advantages.

Patients' Motivation for Surgical Versus Medical Abortion.

Termination of Pregnancy Services in Irish General Practice from January 2019 to June 2019.

Improving experience of medical abortion at home in a changing therapeutic, technological and regulatory landscape: a realist review

Experiences could be improved by offering: an option for self-referral through a telemedicine consultation, realistic information on a range of experiences, opportunities to personalise the process, improved pain relief, and choice of when and how to discuss contraception.

Abortion through telemedicine

There are limitations to the reach of telemedicine because of specific restrictions on mifepristone in the United States as well as laws that specifically prohibit telemedICine for abortion, but if these barriers are removed, teleMedicine can potentially increase abortion access.

Medication Abortion up to 70 Days of Gestation.

Medication Abortion Up to 70 Days of Gestation.

The purpose of this document is to provide updated evidence-based guidance on the provision of medication abortion up to 70 days (or 10 weeks) of gestation.

References

SHOWING 1-10 OF 20 REFERENCES

Serial multilevel urine pregnancy testing to assess medical abortion outcome: a meta-analysis.

Comparison of two low-sensitivity urine pregnancy tests for confirming the success of early medical abortion

The introduction of the single-window low-sensitivity urine pregnancy test (LSPT) has not impacted on the detection of ongoing pregnancy or on contact with the service due to a positive or invalid LSPT.

Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion.

Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited.

Alternatives to a Routine Follow-Up Visit for Early Medical Abortion

Screening algorithms including patient-observed outcomes, a low-sensitivity pregnancy test, and nonsonographic clinical evaluation were as effective as sonography in identifying women who received interventions at or after the follow-up visit.

Can women accurately assess the outcome of medical abortion based on symptoms alone?

First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.

Mifepristone With Buccal Misoprostol for Medical Abortion: A Systematic Review

Outpatient medical abortion regimens with mifepristone followed in 24–48 hours by buccal misoprostol are highly effective for pregnancy termination through 63 days of gestation.

Feasibility of telephone follow-up after medical abortion.

Clinical follow-up compared with self-assessment of outcome after medical abortion: a multicentre, non-inferiority, randomised, controlled trial